March 1, 2012 — Cell>Point announced it entered into a licensing agreement for South Korea, Taiwan, Malaysia, Vietnam and the Philippines with Hyun Imc Co. Ltd., headquartered in Seoul, South Korea, for the kit manufacture, marketing and distribution of Cell>Point’s cancer and cardiology nuclear imaging product.

March 1, 2012 — Philips announced the launch of HeartStart XL+, a crash cart defibrillator/monitor for use in hospitals and other health care facilities that, in AED mode, can defibrillate any patient with no special pads required, which can save valuable time when responding to a cardiac emergency.

March 1, 2012 – Steris Corp. announced they will collaborate with device manufacturer St. Jude Medical Inc. on the planning and implementation of advanced cardiac laboratories for healthcare providers in the United States. The labs feature technologies across the cardiovascular service line for hospitals and clinics interested in developing laboratories that meet their changing clinical needs.

February 29, 2012 — Vessix Vascular Inc. announced initial patient treatments in the international multi-center Reduce-HTN renal denervation clinical study for uncontrolled hypertension.

February 29, 2012 — Lantheus Medical Imaging Inc. announced a strategic distribution arrangement for its Definity cardiac ultrasound contrast agent in the People’s Republic of China, including Hong Kong S.A.R. and Macau S.A.R.

February 28, 2012 — Janssen Research and Development LLC announced that the U.S. Food and Drug Administration (FDA) has assigned a priority review designation to the supplemental new drug application (sNDA) filed Dec. 29, 2011 for Xarelto (rivaroxaban).

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now